[ ![Lock Image](/themes/custom/cosmos/icons/lock-image.png) ](/arctic_media_access_logs_modal_form?media-hcp=12766) 

 

Description

Erenumab has been studied in several large, global, randomized, double-blind, placebo-controlled studies to assess its safety and efficancy in migraine prevention.



 

 

Usage Rights & Restrictions

This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.



 

 [ ![Lock Image](/themes/custom/cosmos/icons/lock-image.png) ](/arctic_media_access_logs_modal_form?media-hcp=12766) 

 [   Download (PDF 223.63 KB)  ](/arctic_media_access_logs_modal_form?media-hcp=12766)